GE Healthcare and Germfree are joining forces to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.   Current market indicators predict a compound annual growth rate of more than 36% in the cell and gene therapy market during 2019-2025. With more than 700 cell and gene therapies currently in clinical trials, demand exceeds supply. The collaboration with Germfree represents a significant contribution to increase capacity and capabil...